We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

11 hedge funds and large institutions have $967K invested in NeuroMetrix, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more capital invested

Capital invested by funds: $253K → $967K (+$714K)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

22% more funds holding

Funds holding: 911 (+2)

Holders
11
Holders Change
+2
Holders Change %
+22.22%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$333K +$370K +12,208 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$226K +$191K +6,286 +315%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$150K +$167K +5,510 New
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$82K +$90.3K +2,976 New
Squarepoint
5
Squarepoint
New York
$73K +$81.6K +2,692 New
TSS
6
Two Sigma Securities
New York
$49K +$54.7K +1,802 New
Citadel Advisors
7
Citadel Advisors
Florida
$46K +$334 +11 +0.7%
BlackRock
8
BlackRock
New York
$5K
UBS Group
9
UBS Group
Switzerland
$3K -$6.58K -217 -70%
VF
10
Virtu Financial
New York
-$127K -5,032 Closed
TRCT
11
Tower Research Capital (TRC)
New York
-$21K -818 Closed
Bank of America
12
Bank of America
North Carolina
+$61 +2 New

NURO Hedge Fund Activity: Q1 2021 in Review

11 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q1 2021, worth a combined $967K — up 282% from $253K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NURO positions and 4 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $370K. The largest seller was Virtu Financial, exiting entirely with an estimated $127K sold.

  • 11 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q1 2021, up from 9 in Q4 2020.
  • Funds reported $967K of NeuroMetrix, Inc. Common Stock stock for Q1 2021, up 282% quarter-over-quarter.
  • 6 funds opened new NeuroMetrix, Inc. Common Stock positions in Q1 2021 and 4 closed out, a net change of +2 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q1 2021 was Renaissance Technologies, an estimated $370K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q1 2021 was Virtu Financial, an estimated $127K sold.

Based on aggregated 13F filings for Q1 2021.